| Sep 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Total Revenues ($Mil): | 326.59 | 257.53 | 213.95 | 150.20 | 144.25 | 85.59 | 38.30 |
| Depreciation & Amort ($Mil): | 1.58 | 1.58 | 1.46 | 0.99 | 1.87 | 1.47 | 0.62 |
| Operating Income ($Mil): | -9.20 | -28.03 | 10.33 | -11.99 | 15.56 | -18.14 | -46.74 |
| Net Income ($Mil): | -2.80 | -18.27 | 63.72 | -7.75 | 16.99 | -45.83 | -45.83 |
| Earnings Per Share ($): | -0.05 | -0.35 | 1.25 | -0.16 | 0.34 | -0.37 | -1.23 |
| Dividends ($): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sep 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Current Assets ($Mil): | 288.78 | 292.18 | 274.32 | 204.57 | 208.20 | 164.95 | 74.14 |
| Current Liabilities ($Mil): | 71.38 | 83.62 | 45.80 | 34.66 | 34.85 | 25.22 | 19.97 |
| Long Term Debt ($Mil): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shares Outstanding (000): | 52080 | 51840 | 50760 | 49720 | 48110 | 47340 | 39300 |
| Common Equity ($Mil): | 295.84 | 277.89 | 269.95 | 170.89 | 171.67 | 140.16 | 53.93 |
| Sep 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Profit Margin (%): | -0.86 | -7.09 | 29.78 | -5.16 | 11.78 | -19.71 | -119.66 |
| Return on Equity (%): | 3.58 | -6.57 | 23.60 | -4.54 | 9.90 | -12.04 | -84.98 |
| Return on Assets (%): | 3 | -5.05 | 20.00 | -3.71 | 8.09 | -10.12 | -60.86 |
| P/E Ratio: | 74 | -60.63 | 17.23 | -137.63 | 84.06 | -61.92 | 0.00 |
| Price/Book: | 3 | 3.96 | 4.05 | 6.41 | 8.01 | 7.74 | 0.00 |
| Debt Equity: | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage: | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1526.67 |
| Book Value ($): | 5.68 | 5.36 | 5.32 | 3.44 | 3.57 | 2.96 | 1.37 |
| Price/Sales: | 4.08 | 2.35 | 5.11 | 7.29 | 9.53 | 12.67 | 0.00 |
| Dividend Payout (%): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |

| AMGEN INC. | +9.10 | 56.09 | |
| GILEAD SCIENCES | -1.80 | 45.91 | |
| CELGENE CORPORA | -8.00 | 58.56 | |
| BIOGEN IDEC INC | -31.90 | 43.13 | |
| STEMCELLS INC. | -56.40 | 1.23 |
